Therefore, determining the BAFF-var status of SLE patients may improve the risk stratification of patients for whom the development of lupus nephritis is more likely and thus may be helpful in the follow-up care and treatment of SLE patients. The gene discussed is TNFSF13B; the disease is lupus nephritis.